Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. BioPharmX Corporation (BPMX) Message Board

Prominent Vendor BiopharmX-Global Acne Drugs Marke

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 223
Posted On: 12/03/2015 7:27:39 PM
Avatar
Posted By: Whos_Who
Prominent Vendor BiopharmX-Global Acne Drugs Market 2016-2020

DUBLIN, Dec. 03, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/2hpc7x/global_acne_drugs) has announced the addition of the "Global Acne Drugs Market 2016-2020" report to their offering.

Rising awareness levels of acne and related treatment products are positively influencing the sales of acne products. Many people are availing different treatment options, increasing the demand for acne drugs. Companies are developing innovative products to meet this rising demand. New products such as Visonac by Photocure are likely to meet consumer needs.

According to the report, many acne drugs are available in the market. However, these drugs provide symptomatic treatment and do not cure the condition. Symptomatic treatment involves the reduction of acne lesions by almost 50% and not the suppression of acne recurrence. Most people with acne use isotretinoin to relieve their condition. However, this drug has teratogenic effects and cannot be prescribed for pregnant women.

Further, the report states that though the available drugs are effective in alleviating acne, they have certain harmful side effects. Dryness, burning, itching, flaking, irritation, and slight puffiness of the skin are some of the side effects of topical acne drugs. Oral drugs can also cause side effects. Solodyn (minocycline), an oral acne drug, has many side effects, and its administration requires medical supervision.

Key questions answered in the report include:

What will the market size and the growth rate be in 2020
What are the key factors driving the global acne drugs market
What are the key Market trendss impacting the growth of the acne drugs market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the vendors in the global acne drugs market
What are the trending factors influencing the market shares of the Americas, APAC, and EMEA
What are the key outcomes of the five forces analysis of the acne drugs market
Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Acne: An overview

PART 06: Pipeline analysis

PART 07: Market landscape

PART 08: Reimbursement scenario for acne drugs

PART 09: Market segmentation by drug class

PART 10: Market segmentation by route of administration

PART 11: Market segmentation by type

PART 12: Global acne drugs market: OTC drugs

PART 13: Geographical segmentation

PART 14: Market drivers

PART 15: Impact of drivers

PART 16: Market challenges

PART 17: Impact of drivers and challenges

PART 18: Market trends

PART 19: Vendor landscape

Key Vendors:

Allergan
Galderma
Stiefel
Valeant
Other Prominent Vendors:

AndroScience
Anterios
Aqua Pharmaceuticals
Astellas
Bayer HealthCare
BioPharmX
Celtaxsys
Cipher Pharmaceuticals
COSMO Pharmaceuticals
Dermira
Elorac
F.Hoffmann-La Roche
Foamix
GlaxoSmithKline
Guthy-Renker
Helix BioMedix
Hygeia Therapeutics
Johnson & Johnson
Meda
Mylan
Novan
Oculus Innovative Sciences
Paratek Pharmaceuticals
Photocure
Promius Pharma
Ranbaxy
Reckitt Benckiser
Skinvisible Pharmaceuticals
Teva
Versapharm
XBiotech


(0)
(0)




BioPharmX Corporation (BPMX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us